SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-22-228660
Filing Date
2022-08-24
Accepted
2022-08-24 17:22:04
Documents
16
Period of Report
2022-08-22
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d383768d8k.htm   iXBRL 8-K 34647
2 EX-1.1 d383768dex11.htm EX-1.1 263477
3 EX-4.1 d383768dex41.htm EX-4.1 97390
4 EX-5.1 d383768dex51.htm EX-5.1 18572
8 GRAPHIC g383768g0825031725558.jpg GRAPHIC 2091
  Complete submission text file 0001193125-22-228660.txt   648829

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA awh-20220822.xsd EX-101.SCH 2528
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE awh-20220822_lab.xml EX-101.LAB 18850
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE awh-20220822_pre.xml EX-101.PRE 11790
10 EXTRACTED XBRL INSTANCE DOCUMENT d383768d8k_htm.xml XML 3648
Mailing Address 12117 BEE CAVES ROAD BUILDING THREE SUITE 100 AUSTIN TX 78738
Business Address 12117 BEE CAVES ROAD BUILDING THREE SUITE 100 AUSTIN TX 78738 512-519-0400
Aspira Women's Health Inc. (Filer) CIK: 0000926617 (see all company filings)

IRS No.: 330595156 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-34810 | Film No.: 221192350
SIC: 2835 In Vitro & In Vivo Diagnostic Substances